10:09 AM EST - COSCIENS Biopharma Inc. : Announced the publication of a new corporate presentation, now available on its website at www.cosciensbio.com. The presentation provides an overview of the Company and its operating subsidiaries, following the recent acquisition of Nualtis Corp. and includes information relating to the ongoing private placement of 15% unsecured convertible debentures. COSCIENS Biopharma Inc.
shares T.CSCI are trading unchanged at $9.16.
